215 related articles for article (PubMed ID: 28972490)
21. Phenotypic analysis of receptor-ligand pairs on B-cells in B-chronic lymphocytic leukemia.
Gagro A; Dasić G; Sabioncello A; Rabatić S; Reckzeh B; Havemann K; Kardum I; Jacksić B; Vitale B
Leuk Lymphoma; 1997 Apr; 25(3-4):301-11. PubMed ID: 9168440
[TBL] [Abstract][Full Text] [Related]
22. Residual cancer lymphocytes in patients with chronic lymphocytic leukemia after therapy show increased expression of surface antigen CD52 detected using quantitative fluorescence cytometry.
Pevna M; Doubek M; Coupek P; Stehlikova O; Klabusay M
Clin Lymphoma Myeloma Leuk; 2014 Oct; 14(5):411-8. PubMed ID: 25066039
[TBL] [Abstract][Full Text] [Related]
23. Type I (CD64) and type II (CD32) Fc gamma receptor-mediated phagocytosis by human blood dendritic cells.
Fanger NA; Wardwell K; Shen L; Tedder TF; Guyre PM
J Immunol; 1996 Jul; 157(2):541-8. PubMed ID: 8752900
[TBL] [Abstract][Full Text] [Related]
24. Antigen modulation followed by quantitative flow cytometry of B-chronic lymphocytic leukemia cells after treatment.
Kusenda J; Babusíková O
Neoplasma; 2004; 51(2):97-102. PubMed ID: 15190418
[TBL] [Abstract][Full Text] [Related]
25. The role of CD180 in hematological malignancies and inflammatory disorders.
Edwards K; Lydyard PM; Kulikova N; Tsertsvadze T; Volpi EV; Chiorazzi N; Porakishvili N
Mol Med; 2023 Jul; 29(1):97. PubMed ID: 37460961
[TBL] [Abstract][Full Text] [Related]
26. Colony-Stimulating Factor-1 Receptor Is Required for Nurse-like Cell Survival in Chronic Lymphocytic Leukemia.
Polk A; Lu Y; Wang T; Seymour E; Bailey NG; Singer JW; Boonstra PS; Lim MS; Malek S; Wilcox RA
Clin Cancer Res; 2016 Dec; 22(24):6118-6128. PubMed ID: 27334834
[TBL] [Abstract][Full Text] [Related]
27. Use of the receptor tyrosine kinase-like orphan receptor 1 (ROR1) as a diagnostic tool in chronic lymphocytic leukemia (CLL).
Uhrmacher S; Schmidt C; Erdfelder F; Poll-Wolbeck SJ; Gehrke I; Hallek M; Kreuzer KA
Leuk Res; 2011 Oct; 35(10):1360-6. PubMed ID: 21531460
[TBL] [Abstract][Full Text] [Related]
28. Dysregulated Fc receptor function in active rheumatoid arthritis.
Magnusson SE; Wennerberg E; Matt P; Lindqvist U; Kleinau S
Immunol Lett; 2014 Nov; 162(1 Pt A):200-6. PubMed ID: 25194756
[TBL] [Abstract][Full Text] [Related]
29. Expression of Toll-like receptor 2 on CD16+ blood monocytes and synovial tissue macrophages in rheumatoid arthritis.
Iwahashi M; Yamamura M; Aita T; Okamoto A; Ueno A; Ogawa N; Akashi S; Miyake K; Godowski PJ; Makino H
Arthritis Rheum; 2004 May; 50(5):1457-67. PubMed ID: 15146415
[TBL] [Abstract][Full Text] [Related]
30. Analysis of CD16+CD56dim NK cells from CLL patients: evidence supporting a therapeutic strategy with optimized anti-CD20 monoclonal antibodies.
Le Garff-Tavernier M; Decocq J; de Romeuf C; Parizot C; Dutertre CA; Chapiro E; Davi F; Debré P; Prost JF; Teillaud JL; Merle-Beral H; Vieillard V
Leukemia; 2011 Jan; 25(1):101-9. PubMed ID: 20975664
[TBL] [Abstract][Full Text] [Related]
31. Increased expression of FcgammaRI/CD64 on circulating monocytes parallels ongoing inflammation and nephritis in lupus.
Li Y; Lee PY; Sobel ES; Narain S; Satoh M; Segal MS; Reeves WH; Richards HB
Arthritis Res Ther; 2009; 11(1):R6. PubMed ID: 19144150
[TBL] [Abstract][Full Text] [Related]
32. Total expression of HLA-G and TLR-9 in chronic lymphocytic leukemia patients.
Własiuk P; Tomczak W; Zając M; Dmoszyńska A; Giannopoulos K
Hum Immunol; 2013 Dec; 74(12):1592-7. PubMed ID: 23994589
[TBL] [Abstract][Full Text] [Related]
33. Empirical Study on Exploring the Role of CD180 and MD-1 Prognostic Indicators for the Chronic Lymphocytic Leukaemia (CLL) Disease.
Alotaibi MA
Pak J Biol Sci; 2023 May; 26(6):311-320. PubMed ID: 37902045
[TBL] [Abstract][Full Text] [Related]
34. Fractionated cyclophosphamide, vincristine, liposomal daunorubicin, and dexamethasone plus rituximab and granulocyte-macrophage-colony stimulating factor (GM-CSF) alternating with methotrexate and cytarabine plus rituximab and GM-CSF in patients with Richter syndrome or fludarabine-refractory chronic lymphocytic leukemia.
Tsimberidou AM; Kantarjian HM; Cortes J; Thomas DA; Faderl S; Garcia-Manero G; Verstovsek S; Ferrajoli A; Wierda W; Alvarado Y; O'Brien SM; Albitar M; Keating MJ; Giles FJ
Cancer; 2003 Apr; 97(7):1711-20. PubMed ID: 12655528
[TBL] [Abstract][Full Text] [Related]
35. Effects of Toll-like receptor 7 and Toll-like receptor 9 signaling stimulators and inhibitors on chronic lymphocytic leukemia cells ex vivo and their interactions with cladribine.
Wolska A; Cebula-Obrzut B; Smolewski P; Robak T
Leuk Lymphoma; 2013 Jun; 54(6):1268-78. PubMed ID: 23078646
[TBL] [Abstract][Full Text] [Related]
36. Human MO subsets as defined by expression of CD64 and CD16 differ in phagocytic activity and generation of oxygen intermediates.
Grage-Griebenow E; Flad HD; Ernst M; Bzowska M; Skrzeczyñska J; Pryjma J
Immunobiology; 2000 May; 202(1):42-50. PubMed ID: 10879688
[TBL] [Abstract][Full Text] [Related]
37. Phenotypic and functional characterization of monocyte-derived dendritic cells in chronic lymphocytic leukaemia patients: influence of neoplastic CD19 cells in vivo and in vitro.
Orsini E; Pasquale A; Maggio R; Calabrese E; Mauro FR; Giammartini E; Guarini A; Foa R
Br J Haematol; 2004 Jun; 125(6):720-8. PubMed ID: 15180861
[TBL] [Abstract][Full Text] [Related]
38. Immune recovery after fludarabine-cyclophosphamide-rituximab treatment in B-chronic lymphocytic leukemia: implication for maintenance immunotherapy.
Ysebaert L; Gross E; Kühlein E; Blanc A; Corre J; Fournié JJ; Laurent G; Quillet-Mary A
Leukemia; 2010 Jul; 24(7):1310-6. PubMed ID: 20463751
[TBL] [Abstract][Full Text] [Related]
39. Phase I study of Rituximab-CHOP regimen in combination with granulocyte colony-stimulating factor in patients with follicular lymphoma.
Niitsu N; Hayama M; Okamoto M; Khori M; Higashihara M; Tamaru J; Hirano M
Clin Cancer Res; 2004 Jun; 10(12 Pt 1):4077-82. PubMed ID: 15217942
[TBL] [Abstract][Full Text] [Related]
40. The Expression of Toll-Like Receptors in Patients with B-Cell Chronic Lymphocytic Leukemia.
Rybka J; Butrym A; Wróbel T; Jaźwiec B; Bogucka-Fedorczuk A; Poręba R; Kuliczkowski K
Arch Immunol Ther Exp (Warsz); 2016 Dec; 64(Suppl 1):147-150. PubMed ID: 28083607
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
